Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 40 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 9 | 1,170−1.7%/yr | −1.7%/yr | 4.41.1× | 62% | 2,150 in 2030+11%/yr |
| Superficial venous ablation |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 10 |
| 562−6.2%/yr |
| −6.2%/yr |
| 2.10.6× |
| 70% |
| 590 in 2030+0.9%/yr |
| Dialysis access | 7 | 526−11%/yr | −11%/yr | 2.10.4× | 3% | 610 in 2030+2.4%/yr |
| Carotid revascularization | 5 | 321−9.6%/yr | −9.6%/yr | 1.21.1× | 0% | 410 in 2030+4.2%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 272−1.9%/yr | −1.9%/yr | 1.10.7× | 0% | 220 in 2030−3.7%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.